Drugs / Antispasmodic Agent
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT07000383 | Jun 2025 → Jul 2026 overdue | irritable bowel syndrome | University Medical Center Ho Chi Minh City (UMC) | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Antispasmodic Agent | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07000383 ↗ |
| Route | Oral | “An oral antispasmodic medication, prescribed according to standard clinical practice for IBS-D.” NCT07000383 ↗ |